Taurus Asset Management, LLC Abb Vie Inc. Transaction History

Taurus Asset Management, LLC

$944 Million
Q2 2024

A detailed history of Taurus Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Taurus Asset Management, LLC holds 6,182 shares of ABBV stock, worth $1.25 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

6,182

Previous 6,307 1.98%

Holding current value

$1.25 Million

Previous $1.15 Million 7.67%

% of portfolio

0.11%

Previous 0.12%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$154.79 - $180.76 $19,348 - $22,595	-125 Reduced 1.98%	6,182 $1.06 Million
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $151,829 - $172,995	-950 Reduced 13.09%	6,307 $1.15 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $110,211 - $127,586	-825 Reduced 10.21%	7,257 $1.08 Million
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $145,622 - $167,705	-1,007 Reduced 11.08%	8,082 $1.29 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $178,906 - $227,448	-1,300 Reduced 12.51%	9,089 $1.39 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $84,335 - $104,636	-639 Reduced 5.79%	10,389 $1.68 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $171,888 - $217,488	-1,600 Reduced 12.67%	11,028 $1.49 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $210,140 - $238,540	-1,975 Reduced 13.52%	12,628 $1.36 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $10,521 - $11,721	-100 Reduced 0.68%	14,603 $1.65 Million
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $355,799 - $391,692	-3,478 Reduced 19.13%	14,703 $1.59 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $56,343 - $76,069	-700 Reduced 3.71%	18,181 $1.95 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $1.62 Million - $1.9 Million	-18,881 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $8,804 - $11,781	120 Added 0.64%	18,881 $1.85 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $32,250 - $48,895	-500 Reduced 2.6%	18,761 $1.43 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $1.39 Million - $1.74 Million	19,261 New	19,261 $1.71 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $1.24 Million - $1.49 Million	-19,661 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $2.25 Million - $2.87 Million	-34,197 Reduced 63.49%	19,661 $1.43 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $40,961 - $48,209	-531 Reduced 0.98%	53,858 $4.34 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $29,427 - $36,291	-378 Reduced 0.69%	54,389 $5.01 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $37,348 - $44,191	-416 Reduced 0.75%	54,767 $5.07 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $205,090 - $274,635	-2,229 Reduced 3.88%	55,183 $5.22 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $80,604 - $88,389	-900 Reduced 1.54%	57,412 $5.55 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $4.07 Million - $5.2 Million	58,312	58,312 $5.18 Million

Others Institutions Holding ABBV

# of Institutions

3,778

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $357B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taurus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Taurus Asset Management, LLC with notifications on news.

Account

Taurus Asset Management, LLC Abb Vie Inc. Transaction History